The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, randomized, controlled, open-label, phase 2 study of the PD-1/IL-2a-bias bispecific antibody fusion protein IBI363 in mucosal and acral melanoma.
 
Bin Lian
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Zhiguo Luo
No Relationships to Disclose
 
Xiaoshi Zhang
No Relationships to Disclose
 
Di Wu
No Relationships to Disclose
 
Ke Li
No Relationships to Disclose
 
Zhengyun Zou
No Relationships to Disclose
 
Meiyu Fang
No Relationships to Disclose
 
Chen Jing
No Relationships to Disclose
 
Huijing Feng
No Relationships to Disclose
 
Yu Jiang
No Relationships to Disclose
 
Weizhen Zhang
No Relationships to Disclose
 
Xianan Li
No Relationships to Disclose
 
Renbing Jiang
No Relationships to Disclose
 
Enwen Wang
No Relationships to Disclose
 
Cuihua Yi
No Relationships to Disclose
 
Yinbin Zhang
No Relationships to Disclose
 
Xueying Zhang
No Relationships to Disclose
 
Xiubao Ren
No Relationships to Disclose
 
Jun Guo
Consulting or Advisory Role - Bayer; MSD; Novartis; Oriengene; Pfizer; Roche; Shanghai Junshi BioSciences; Simcere